Innovative in vitro method to develop easy-to-swallow medicine for children and older people

Scientists at the University of Surrey and University College London have revealed an innovative in vitro method that can help to develop easy to swallow medicine for children and older people.

In an article published by the European Journal of Pharmaceutical Sciences, scientists compared traditional sensory tests and the new in vitro method that was able to explain why smaller multiparticulates eased the travel of medicine from the mouth into the throat and body, reducing mouth residue.

The new test let scientists easily screen different compositions of the carrier liquid and concentration of the particulates, in order to make swallowing as easy as possible.

Dr Marco Ramaioli, Senior Lecturer at the University of Surrey and co-author of the study, said: "Many young children and older people find conventional tablets hard to swallow - making it difficult for them to complete drug therapy. We hope that this in vitro method, together with sensory tests, will help to develop novel medicines that could improve the lives of many people across the world."

Professor Catherine Tuleu from UCL School of Pharmacy commented: "It is exciting to see advancements in age-appropriate medicine design such as multiparticulate systems but successful therapeutic outcomes rely on the development of appropriate administration vehicles."

Dr Mine Orlu, also from UCL School of Pharmacy, added: "The availability of predictive models to characterize the promising formulation platforms early during medicine development is key to producing medicines that are easier to take for patients with different swallowing capabilities."

Source: https://www.surrey.ac.uk/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Historic pledges made to protect children from violence worldwide